Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2026-02-21 @ 3:50 PM
Study NCT ID:
NCT02513459
Status:
COMPLETED
Last Update Posted:
2020-04-24
First Post:
2015-07-30
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's Disease
Sponsor:
AbbVie
Organization: